Results 221 to 230 of about 25,851 (276)
CHK1 inhibition rescues abnormal glycogen buildup in a Caenorhabditis elegans model for glycogen storage disease III. [PDF]
Daghar H +6 more
europepmc +1 more source
Congenital nephrotic syndrome in a newborn with glycogen storage disease and Wilms tumor 1 (WT1) mutation. [PDF]
Annicchiarico Petruzzelli L +9 more
europepmc +1 more source
Generation and characterization of a novel Gaa compound heterozygous mouse model recapitulating human Pompe disease. [PDF]
Huang W +7 more
europepmc +1 more source
Glycophagy: molecular mechanisms, regulatory signals, and disease associations. [PDF]
Chen L, Jiang J, Liu M, Chen L.
europepmc +1 more source
The kidney in genetic metabolic disorders. [PDF]
Schultheiss UT, Schumann A.
europepmc +1 more source
Life-expectancy in glycogen storage disease type I (GSD I) has improved considerably. Its relative rarity implies that no metabolic centre has experience of large series of patients and experience with long-term management and follow-up at each centre is limited. There is wide variation in methods of dietary and pharmacological treatment.
Philippe Labrune +2 more
exaly +7 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Renal Disease in Type I Glycogen Storage Disease
New England Journal of Medicine, 1988Although kidney enlargement occurs in Type I glycogen storage disease, renal disease has not been considered a major problem. Death from renal failure in three patients known to us prompted a study of renal function in this disorder. Of the 38 patients with Type I glycogen storage disease under our care, the 18 children under 10 years old had normal ...
Yuan-Tsong Chen +2 more
exaly +4 more sources

